Skip to main content

Weather Alert

Hurricane activity is severely impacting Quest locations across the Southeast. We ask that patients please double check your appointment status to ensure your designated Patient Service Center is operational.

Hide
Quest Diagnostics

Associations of Beta-amyloid and Alzheimer’s Disease Risk With Patient Age in Over 2,000 Plasma Specimens Analyzed by LC-MS/MS

Alzheimer’s Association International Conference 

AAIC 2023

Amsterdam, Netherlands and virtual,  July 16 – 20. 2023

Poster presentation: Associations of Beta-amyloid and Alzheimer’s Disease Risk with Patient Age in Over 2,000 Plasma Specimens Analyzed by LC-MS/MS

Authors: Weber DM, Kim JC, Goldman SM, Clarke NJ, Racke MK

Specialty: Neurology

Related content

On-Demand Webinar
Assessing Alzheimer's Disease Risk in Primary Care Settings
On-Demand Webinar
The Emerging Role of Blood-based Biomarkers in Alzheimer's Disease
On-Demand Webinar
Dementia: Prevention, Diagnosis, & Management
Audio Podcast
Assessing for Alzheimer’s Disease with Quest Diagnostics
Audio Podcast
Alzheimer’s Disease: A New Generation of Screenings and Therapies on the Horizon
Audio Podcast
Patient-minded Neurology

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.